Matches in Wikidata for { <http://www.wikidata.org/entity/Q83210605> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q83210605 description "2012 թվականին հրատարակված գիտական հոդված" @default.
- Q83210605 description "artikull shkencor i botuar më 01 janar 2012" @default.
- Q83210605 description "artículu científicu espublizáu en xineru de 2012" @default.
- Q83210605 description "scientific article published on 01 January 2012" @default.
- Q83210605 description "wetenschappelijk artikel" @default.
- Q83210605 description "наукова стаття, опублікована в січні 2012" @default.
- Q83210605 description "научна статия" @default.
- Q83210605 name "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 name "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 name "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 type Item @default.
- Q83210605 label "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 label "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 label "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 prefLabel "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 prefLabel "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 prefLabel "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 P1433 Q83210605-2D540A69-31D5-4D80-8450-EAB2F71D3925 @default.
- Q83210605 P1476 Q83210605-01E93429-D3E0-41F2-8C75-CCB1CE021254 @default.
- Q83210605 P2093 Q83210605-0D7BE8C4-5EDB-442B-BACE-E62CC27A2173 @default.
- Q83210605 P2093 Q83210605-18B4EBF8-6D6B-4CC8-8C5A-BB6D0D2AFE09 @default.
- Q83210605 P2093 Q83210605-1982B331-617D-47B1-BC34-B9A44E7DE056 @default.
- Q83210605 P2093 Q83210605-34C4CC56-ABF8-42E8-8DBC-662F1494CB1E @default.
- Q83210605 P2093 Q83210605-361BB426-CAAB-4148-B576-B0245B93086A @default.
- Q83210605 P2093 Q83210605-8143C432-9BDC-4CDC-ACF1-5ABC2BB8AAC5 @default.
- Q83210605 P2093 Q83210605-A0228FC2-D406-45A3-A064-B9D28AE8D3F4 @default.
- Q83210605 P2093 Q83210605-CC1D8D26-A407-4334-ACF2-2344D8A0F96C @default.
- Q83210605 P2093 Q83210605-CDC9E933-B38E-4888-9B53-A29D00728F43 @default.
- Q83210605 P2093 Q83210605-E35027EB-E573-4A01-9171-FA4B62648761 @default.
- Q83210605 P2093 Q83210605-F63EFA2A-51ED-4877-A5B5-5A53012836C8 @default.
- Q83210605 P304 Q83210605-F1490938-0CA3-4593-A980-3FF527526D21 @default.
- Q83210605 P31 Q83210605-7149DC42-4EA7-49D9-9032-F8063ECD233B @default.
- Q83210605 P356 Q83210605-68389160-3C4D-4F0C-A515-A87C29C2DBB7 @default.
- Q83210605 P433 Q83210605-0C95FD5F-EC2B-459A-9560-7905606F50BE @default.
- Q83210605 P478 Q83210605-228875D7-0536-4FDE-9BBD-A92CF21650D6 @default.
- Q83210605 P577 Q83210605-C484B5D8-A1AB-443E-A92B-BB8586EB6B71 @default.
- Q83210605 P698 Q83210605-32144246-584B-4EC1-A90C-83AEDD335600 @default.
- Q83210605 P921 Q83210605-22461137-4A4F-431A-ACF4-F4BE7939E4CD @default.
- Q83210605 P921 Q83210605-86C4596B-0C96-4305-9B10-EA27F426C622 @default.
- Q83210605 P921 Q83210605-978BEFAF-F17D-43B6-BFAD-72BEF0772B57 @default.
- Q83210605 P921 Q83210605-98259445-ABB1-4E97-B7B3-0BF700C6741D @default.
- Q83210605 P356 07357907.2011.629380 @default.
- Q83210605 P698 22236191 @default.
- Q83210605 P1433 Q325953 @default.
- Q83210605 P1476 "CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab" @default.
- Q83210605 P2093 "Alessandra Pascucci" @default.
- Q83210605 P2093 "Antonella Licchetta" @default.
- Q83210605 P2093 "Edoardo Francini" @default.
- Q83210605 P2093 "Giandomenico Roviello" @default.
- Q83210605 P2093 "Gianluca Bargagli" @default.
- Q83210605 P2093 "Giuseppe Marzocca" @default.
- Q83210605 P2093 "Guido Francini" @default.
- Q83210605 P2093 "Multidisciplinary Oncology Group On Gastrointestinal Tumors" @default.
- Q83210605 P2093 "Raffaele Conca" @default.
- Q83210605 P2093 "Roberto Petrioli" @default.
- Q83210605 P2093 "Salvatora Tindara Miano" @default.
- Q83210605 P304 "65-71" @default.
- Q83210605 P31 Q13442814 @default.
- Q83210605 P356 "10.3109/07357907.2011.629380" @default.
- Q83210605 P433 "1" @default.
- Q83210605 P478 "30" @default.
- Q83210605 P577 "2012-01-01T00:00:00Z" @default.
- Q83210605 P698 "22236191" @default.
- Q83210605 P921 Q188874 @default.
- Q83210605 P921 Q25493920 @default.
- Q83210605 P921 Q413299 @default.
- Q83210605 P921 Q422327 @default.